Showing results (21-30 of 135) with videos related to

Sort By:
Pageof 14
Nanotechnology|August 27, 2013
Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapyLuís F F Neves, John J Krais, Brent D Van Rite, et al.
Education for Primary Care : an Official Publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors|April 3, 2010
Moving general practitioner training into primary care with cluster-based learning: a qualitative study in the West MidlandsManjo Doug, Neil Johnson, Martin Wilkinson
Npj Complexity|November 5, 2024
How U.S. Presidential elections strengthen global hate networksAkshay Verma, Richard Sear, Neil Johnson
The British Journal of Psychiatry : the Journal of Mental Science|February 3, 2007
Police contact within 3 months of suicide and associated health service contactKeith R Linsley, Neil Johnson, Jessica Martin
Molecular Cancer Therapeutics|May 20, 2017
Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and CyclophosphamideJohn J Krais, Needa Virani, Patrick H McKernan, et al.
Cell Reports|September 27, 2018
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor ResistanceJoseph Nacson, John J Krais, Andrea J Bernhardy, et al.
Expert Opinion on Drug Delivery|February 9, 2018
Use of spacers for patients treated with pressurized metered dose inhalers: focus on the VENTOLIN™ Mini SpacerGregor Anderson, Neil Johnson, Aruni Mulgirigama, et al.
Journal of Molecular Biology|November 18, 2023
Brca1 Mouse Models: Functional Insights and Therapeutic OpportunitiesWei-Ting Yueh, David J Glass, Neil Johnson
Scientific Reports|December 1, 2023
Explaining conflict violence in terms of conflict actor dynamicsKaterina Tkacova, Annette Idler, Neil Johnson, et al.
Journal of Health Economics and Outcomes Research|September 25, 2024
Health-Related Quality-of-Life Utility Values in Adults With Late-Onset Pompe Disease: Analyses of EQ-5D Data From the PROPEL Clinical TrialAlasdair MacCulloch, Alison Griffiths, Neil Johnson, et al.
Pageof 14